Lv1
50 积分 2025-05-29 加入
Extent and content of data for regulatory submissions: First-in-human and marketing authorization--Viewpoint of US industry
6小时前
求助中
Question-based review for pharmaceutical development: An enhanced quality approach
6小时前
已完结
Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluation
6小时前
求助中
皖公网安备34019202002308
